Download PDF
CC BY-NC-ND 4.0 · Indian J Plast Surg 2017; 50(02): 193-200
DOI: 10.4103/ijps.IJPS_245_15
Original Article
Association of Plastic Surgeons of India

Management of vascular anomalies: Review of institutional management algorithm

Lalit K. Makhija
Department of Plastic Surgery, PGIMER, Dr. RML Hospital, New Delhi, India
,
Sameek Bhattacharya
Department of Plastic Surgery, PGIMER, Dr. RML Hospital, New Delhi, India
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2019 (online)

Also available at
   Permissions and Reprints

ABSTRACT

Introduction: Vascular anomalies are congenital lesions broadly categorised into vascular tumour (haemangiomas) and vascular dysmorphogenesis (vascular malformation). The management of these difficult problems has lately been simplified by the biological classification and multidisciplinary approach. To standardise the treatment protocol, an algorithm has been devised. The study aims to validate the algorithm in terms of its utility and presents our experience in managing vascular anomalies. Materials and Methods: The biological classification of Mulliken and Glowacki was followed. A detailed algorithm for management of vascular anomalies has been devised in the department. The protocol is being practiced by us since the past two decades. The data regarding the types of lesions and treatment modality used were maintained. Results and Conclusion: This study was conducted from 2002 to 2012. A total of 784 cases of vascular anomalies were included in the study of which 196 were haemangiomas and 588 were vascular malformations. The algorithmic approach has brought an element of much-needed objectivity in the management of vascular anomalies. This has helped us to define the management of particular lesion considering its pathology, extent and aesthetic and functional consequences of ablation to a certain extent.

KEY WORDS

Algorithm - management - vascular malformation
 

  • REFERENCES

  • 1 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-22
    CrossrefPubMedGoogle Scholar
  • 2 Balakrishnan G. Vascular anomalies of upper limb. Ind J. Plast Surg 2011; 44: 276-82
    Google Scholar
  • 3 Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: Clinical application of a new classification. J Pediatr Surg 1983; 18: 894-900
    CrossrefPubMedGoogle Scholar
  • 4 Sachin K, Rashmi S, Manish S, Siddhartha W, Uday L. Haemangiomas and venous malformations of the head and neck: A retrospective analysis of endovascular management in 358 patients. Indian J Plast Surg 2013; 46: 109-16
    CrossrefPubMedGoogle Scholar
  • 5 Ye CS, Pan LX, Huang YB, Han AJ, Ye RY, Li SQ. et al. Clinical analysis of vascular anomalies: A hospital-based retrospective study of 592 patients in Southeast China. Chin Med J (Engl) 2011; 124: 3008-12
    Google Scholar
  • 6 Hemangioma Investigator Group. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC. et al. Prospective study of infantile hemangiomas: Demographic, prenatal, and perinatal characteristics. J Pediatr 2007; 150: 291-4
    CrossrefPubMedGoogle Scholar
  • 7 North PE, Waner M, Brodsky MC. Are infantile hemangiomas of placental origin?. Ophthalmology 2002; 109: 633-4
    CrossrefPubMedGoogle Scholar
  • 8 Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood 2004; 103: 1373-5
    CrossrefPubMedGoogle Scholar
  • 9 Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC. et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008; 118: 2592-9
    PubMedGoogle Scholar
  • 10 Ronchese F. The spontaneous involution of cutaneous vascular tumors. Am J Surg 1953; 86: 376-86
    CrossrefPubMedGoogle Scholar
  • 11 Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P. et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124: 1447-56
    CrossrefPubMedGoogle Scholar
  • 12 Cushing SL, Boucek RJ, Manning SC, Sidbury R, Perkins JA. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas. Otolaryngol Head Neck Surg 2011; 144: 78-84
    CrossrefPubMedGoogle Scholar
  • 13 Richter GT, Friedman AB. Hemangiomas and vascular malformations: Current theory and management. Int J Pediatr 2012; 2012: 645678
    CrossrefPubMedGoogle Scholar
  • 14 Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds Jr. JL, Hoffer FA. et al. Lymphatic malformations: Current cellular and clinical investigations. Otolaryngol Head Neck Surg 2010; 142: 789-94
    CrossrefPubMedGoogle Scholar
  • 15 Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: Distinct clinicopathologic and genetic entities. Arch Dermatol 2004; 140: 971-6
    PubMedGoogle Scholar
  • 16 Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: A review of 49 cases. Lasers Surg Med 2007; 39: 563-8
    CrossrefPubMedGoogle Scholar
  • 17 Izikson L, Aderson RR. Treatment endpoint of resistant portwine stain with a 755 nm laser. J Cosmetic Laser Therapy 2009; 11: 52-5
    Google Scholar
  • 18 Tark KC, Lew DH, Lee DW. The fate of long-standing port-wine stain and its surgical management. Plast Reconstr Surg 2011; 127: 784-91
    CrossrefPubMedGoogle Scholar
  • 19 Zeng RS, Liu XQ, Wang AX, Wang DW, Wang JN. Sequential treatment of giant lymphatic malformation of the tongue combined with severe oral and maxillofacial deformities. J Oral Maxillofac Surg 2008; 66: 2364-71
    CrossrefPubMedGoogle Scholar
  • 20 Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ. OK-Collaborative Study Group. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 2009; 119: 107-15
    CrossrefPubMedGoogle Scholar
  • 21 Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 2008; 43: 451-60
    CrossrefPubMedGoogle Scholar
  • 22 Okada A, Kubota A, Fukuzawa M, Imura K, Kamata S. Injection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg 1992; 27: 440-3
    CrossrefPubMedGoogle Scholar
  • 23 Glade RS, Buckmiller LM. CO2 laser resurfacing of intraoral lymphatic malformations: A 10-year experience. Int J Pediatr Otorhinolaryngol 2009; 73: 1358-61
    CrossrefPubMedGoogle Scholar
  • 24 Glade RS, Richter GT, James CA, Suen JY, Buckmiller LM. Diagnosis and management of pediatric cervicofacial venous malformations: Retrospective review from a vascular anomalies center. Laryngoscope 2010; 120: 229-35
    CrossrefPubMedGoogle Scholar
  • 25 Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds Jr. JL, Hoffer FA. et al. Lymphatic malformations: Review of current treatment. Otolaryngol Head Neck Surg 2010; 142: 795-803 803.e1
    CrossrefPubMedGoogle Scholar
  • 26 Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: Complications and results. Plast Reconstr Surg 1999; 104: 1-11
    PubMedGoogle Scholar
  • 27 Wang YA, Zheng JW, Zhu HG, Ye WM, He Y, Zhang ZY. Sclerotherapy of voluminous venous malformation in head and neck with absolute ethanol under digital subtraction angiography guidance. Phlebology 2010; 25: 138-44
    CrossrefPubMedGoogle Scholar
  • 28 Bradley JP, Zide BM, Berenstein A, Longaker MT. Large arteriovenous malformations of the face: Aesthetic results with recurrence control. Plast Reconstr Surg 1999; 103: 351-61
    CrossrefPubMedGoogle Scholar